| ||||||||
|
||||||||
|
||||||||
|
||||||||
| Or | ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "D"
Results 111 - 120 of 1308 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| Cramer, D W C L Pearce, A H Wu, S A Gayther, A E Bale, P A Beck, J Beesley, S Chanock, D W Cramer, R DiCioccio, R Edwards, Z S Fredericksen, M García-Closas, E L Goode, A C Green, L C Hartmann, E Hogdall, S K Kjær, J Lissowska, V McGuire, F Modugno, K Moysich, R B Ness, S J Ramus, H A Risch, T A Sellers, H Song, D O Stram, K L Terry, P M Webb, D C Whiteman, A S Whittemore, W Zheng, P D P Pharoah, G Chenevix-Trench, M C Pike, J Schildkraut and A Berchuck Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis advance online publication, 2008-01-22 00:00:00.000; doi:10.1038/sj.bjc.6604170 Abstract | Full article | PDF |
||||||||
| Cranston, D J J Ord, E Streeter, A Jones, K Le Monnier, D Cranston, J Crew, S P Joel, M A Rogers, R E Banks, I S D Roberts and A L Harris Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma advance online publication, 2005-05-31 00:00:00.000; doi:10.1038/sj.bjc.6602650 Abstract | Full article | PDF J J Ord, E H Streeter, I S D Roberts, D Cranston and A L Harris Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer advance online publication, 2005-07-19 00:00:00.000; doi:10.1038/sj.bjc.6602666 Abstract | Full article | PDF |
||||||||
| Cranston, D W R O Illing, J E Kennedy, F Wu, G R ter Haar, A S Protheroe, P J Friend, F V Gleeson, D W Cranston, R R Phillips and M R Middleton The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population advance online publication, 2005-09-27 00:00:00.000; doi:10.1038/sj.bjc.6602803 Abstract | Full article | PDF |
||||||||
| Crawford, D J Cebon, M Findlay, C Hargreaves, M Stockler, P Thompson, M Boyer, S Roberts, A Poon, A M Scott, V Kalff, G Garas, A Dowling, D Crawford, J Ring, R Basser, A Strickland, G Macdonald, M Green, A Nowak, B Dickman, H Dhillon and V Gebski Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide doi:10.1038/sj.bjc.6603674 Abstract | Full article | PDF |
||||||||
| Crivellari, D J Bernhard, D Zahrieh, A S Coates, R D Gelber, M Castiglione-Gertsch, E Murray, J F Forbes, L Perey, J Collins, R Snyder, C-M Rudenstam, D Crivellari, A Veronesi, B Thürlimann, M F Fey, K N Price, A Goldhirsch and C Hürny Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer advance online publication, 2004-11-16 00:00:00.000; doi:10.1038/sj.bjc.6602230 Abstract | Full article | PDF |
||||||||
| Cronin-Fenton, D T L Lash, L Pedersen, D Cronin-Fenton, T P Ahern, C L Rosenberg, K L Lunetta, R A Silliman, S Hamilton-Dutoit, J P Garne, M Ewertz and H T Sørensen Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram advance online publication, 2008-07-29 00:00:00.000; doi:10.1038/sj.bjc.6604533 Abstract | Full article | PDF |
||||||||
| Cronin-Fenton, D P D P Cronin-Fenton, M Nørgaard, J Jacobsen, J P Garne, M Ewertz, T L Lash and H T Sørensen Comorbidity and survival of Danish breast cancer patients from 1995 to 2005 advance online publication, 2007-04-03 00:00:00.000; doi:10.1038/sj.bjc.6603717 Abstract | Full article | PDF A-E Carsin, L Sharp, D P Cronin-Fenton, A Ó Céilleachair and H Comber Inequity in colorectal cancer treatment and outcomes: a population-based study advance online publication, 2008-07-01 00:00:00.000; doi:10.1038/sj.bjc.6604467 Abstract | Full article | PDF |
||||||||
| Cruickshank, D A R Clamp, J Mäenpää, D Cruickshank, J Ledermann, P M Wilkinson, R Welch, S Chan, P Vasey, B Sorbe, A Hindley and G C Jayson SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer advance online publication, 2005-12-13 00:00:00.000; doi:10.1038/sj.bjc.6602910 Abstract | Full article | PDF |
||||||||
| Cunningham, D I Chau, A R Norman, D Cunningham, J S Waters, C Topham, G Middleton, M Hill, P J Ross, R Katopodis, G Stewart and J R Oates Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy advance online publication, 2004-09-14 00:00:00.000; doi:10.1038/sj.bjc.6602169 Abstract | Full article | PDF M Ng, J Waters, D Cunningham, I Chau, A Horwich, M Hill, A R Norman, A Wotherspoon and D Catovsky Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma advance online publication, 2005-04-05 00:00:00.000; doi:10.1038/sj.bjc.6602514 Abstract | Full article | PDF K Sumpter, C Harper-Wynne, D Cunningham, S Rao, N Tebbutt, A R Norman, C Ward, T Iveson, M Nicolson, T Hickish, M Hill and J Oates Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF doi:10.1038/sj.bjc.6602572 Abstract | Full article | PDF S Rao, D Cunningham, R E Hawkins, M E Hill, D Smith, F Daniel, P J Ross, J Oates and A R Norman Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer advance online publication, 2005-04-26 00:00:00.000; doi:10.1038/sj.bjc.6602576 Abstract | Full article | PDF G Chong, J L B Dickson, D Cunningham, A R Norman, S Rao, M E Hill, T J Price, J Oates and N Tebbutt Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan advance online publication, 2005-08-09 00:00:00.000; doi:10.1038/sj.bjc.6602733 Abstract | Full article | PDF N R Maisey, A R Norman, A Hill, A Massey, J Oates and D Cunningham CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials advance online publication, 2005-09-20 00:00:00.000; doi:10.1038/sj.bjc.6602760 Abstract | Full article | PDF S Burton, G Brown, I R Daniels, A R Norman, B Mason and D Cunningham MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? doi:10.1038/sj.bjc.6602947 Abstract | Full article | PDF C Burton, D Linch, P Hoskin, D Milligan, M J S Dyer, B Hancock, P Mouncey, P Smith, W Qian, K MacLennan, A Jack, A Webb and D Cunningham A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma advance online publication, 2006-02-28 00:00:00.000; doi:10.1038/sj.bjc.6602975 Abstract | Full article | PDF G Chong and D Cunningham Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan advance online publication, 2006-02-21 00:00:00.000; doi:10.1038/sj.bjc.6603022 Abstract | Full article | PDF I Chau, D Cunningham, C Russell, A R Norman, T Kurzawinski, P Harper, P Harrison, G Middleton, F Daniels, T Hickish, J Prendeville, P J Ross, B Theis, R Hull, M Walker, N Shankley, B Kalindjian, G Murray, A Gillbanks and J Black Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials advance online publication, 2006-04-04 00:00:00.000; doi:10.1038/sj.bjc.6603058 Abstract | Full article | PDF N Starling, D Tilden, J White and D Cunningham Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment doi:10.1038/sj.bjc.6603561 Abstract | Full article | PDF V Formica, A Wotherspoon, D Cunningham, A R Norman, B Sirohi, J Oates and G Chong The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract advance online publication, 2007-04-03 00:00:00.000; doi:10.1038/sj.bjc.6603699 Abstract | Full article | PDF A Sultana, C Tudur Smith, D Cunningham, N Starling, D Tait, J P Neoptolemos and P Ghaneh Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy advance online publication, 2007-04-03 00:00:00.000; doi:10.1038/sj.bjc.6603719 Abstract | Full article | PDF A Sultana, C Tudur Smith, D Cunningham, N Starling, J P Neoptolemos and P Ghaneh Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses advance online publication, 2008-06-24 00:00:00.000; doi:10.1038/sj.bjc.6604436 Abstract | Full article | PDF |
||||||||
| Currow, D C H E Uronis, D C Currow, D C McCrory, G P Samsa and A P Abernethy Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis advance online publication, 2008-01-08 00:00:00.000; doi:10.1038/sj.bjc.6604161 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||